|
SAM-e offers exciting support for Fibromyalgia. There are very few drugs that can offer relief from this debilitating condition. SAM-e, however, has been shown to provide benefits equal to or even surpassing those of conventional drugs without side effects. One of the first studies of SAM-e and Fibromyalgia was done in Italy in 1987. 70 people were studied. In this study one group received SAM-e, and the other placebo. At the end of 21 days, both groups stopped any treatment for 14 days. Then the two groups switched treatments. Researchers found that patients experienced a significant improvement in mood and a decrease in tender points when they where taking the SAM-e. When taking placebo, they did not experience this relief. Doctors made this statement, " SAM-e seems to be an effective and safe therapy in the management of Fibromyalgia". A subsequent 6 week study in 1991 in Denmark by Dr. Jacobsen a team of over 40 patients found that those who had taken SAM-e experienced improvements. Researches reported, " It has some beneficial effects on primary Fibromyalgia and could be an important option in the treatment hereof". A 1991 study in Italy of 47 patients found SAM-e "proved to be effective in relieving pain and suppressed mood" while improving sleep quality.*
|
* The information contained herein was gathered
from various scientific studies conducted
by professionals both domestically and abroad.
These statements have not been evaluated by
the FDA. Therefore, this product, being sold
as a food supplement, is not intended to diagnose,
treat, cure, or prevent any disease. |